PGEN
Precigen, Inc. Common Stock
Nasdaq · usd
Precigen, Inc. Common Stock (PGEN) trades at $4.47 (+5.92%) as of 7:53:28 PM EST on Nov 6, 2026, -41.18% over the past month. Market cap is $1.51B, with 10.2 days to cover in short interest.
Stock performance
How Precigen, Inc. Common Stock (PGEN) stock has performed from one day to one year, with its 52-week range.
- 1D
- +5.92%
- 1W
- -35.59%
- 1M
- -41.18%
- YTD
- +6.94%
- 1Y
- +11.75%
- 52-wk range
- $3.04 – $8.98
Key statistics
Today's trading snapshot for PGEN: day range, open, previous close, volume and market cap.
- Day range
- $4.03 – $4.48
- Open
- $4.32
- Prev close
- $4.22
- Volume
- 9.24M
- Market cap
- $1.51B
- Shares out
- 356.51M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Precigen, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- 18.70
- P/B
- 36.78
- P/FCF
- —
- ROE
- -772.7%
- ROA
- -197.7%
- Debt/Equity
- 2.15
- Div yield
- 0.00%
As of Nov 6, 2026
8-K filings
Material corporate events Precigen, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Quarterly earningsNov 5, 2026
Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated November 4, 2026, reporting its financial results for the quarter ended September 30, 2026.
- Quarterly earningsAug 4, 2026
Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated August 4, 2026, reporting its financial results for the quarter ended June 30, 2026.
- Annual meeting resultsJun 24, 2026
At the 2026 Annual Meeting, the Company's stockholders (i) elected each of the persons listed below as a director for a one-year term, (ii) ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, (iii) approved a non-binding advisory resolution approving the compensation of the named executive officers, and (iv) approved the 2023 Plan Amendment No. 3.
- Quarterly earningsMay 13, 2026
Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated May 13, 2026, reporting its financial results for the quarter ended March 31, 2026.
- Quarterly earningsNov 13, 2025
Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated November 13, 2025, reporting its financial results for the quarter ended September 30, 2025.
PGEN short interest
How heavily PGEN is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 10.2
- Short interest
- 46.39M
- Avg volume
- 4.54M
As of · reported to FINRA twice monthly.
PGEN news
The latest news and headlines about Precigen, Inc. Common Stock (PGEN).
- Precigen, Inc. (PGEN) Q3 Earnings and Revenues Miss EstimatesneutralZacks Investment Research· Nov 4, 2026
- Precigen Gears Up to Report Q3 Earnings: What Can Investors Expect?negativeZacks Investment Research· Nov 2, 2026
- Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in FocuspositiveZacks Investment Research· Oct 5, 2026
- 4 Low-Beta Healthcare Stocks to Buy Amid Fears of Another Rate HikepositiveZacks Investment Research· Oct 2, 2026
- Precigen (PGEN) Soars 6.3%: Is Further Upside Left in the Stock?positiveZacks Investment Research· Oct 1, 2026
Frequently asked questions
What is the Precigen, Inc. Common Stock (PGEN) stock price today?
Precigen, Inc. Common Stock (PGEN) is trading at $4.47 (+5.92% on the day) as of 7:53:28 PM EST on Nov 6, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Precigen, Inc. Common Stock?
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms.
What is the short interest in PGEN?
As of Oct 15, 2026, PGEN has 46.39M shares short and 10.2 days to cover.
What exchange is PGEN listed on?
Precigen, Inc. Common Stock (PGEN) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of PGEN with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a PGEN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.